Article 3 of Implementing Decision (EU) 2020/1353 is replaced by the following:
‘Article 3
Poland may finance the following measures:
(a)
a reduction in social security contributions, as provided for in Art. 31zo of the “Act of 2 March 2020 on specific solutions related to the prevention, counteraction and eradication of COVID-19, other infectious diseases and crisis situations caused by them”, for the part of expenditure related to the support of self-employed persons, all social cooperatives (regardless of the number of employees) and, for companies employing up to 50 people, the part of expenditure in respect of employees who were continuously in employment;
(b)
a downtime benefit for self-employed persons and those working under civil law contracts, as provided for in Art. 15zq and 15zua of the “Act of 2 March 2020 on specific solutions related to the prevention, counteraction and eradication of COVID-19, other infectious diseases and crisis situations caused by them”;
(c)
subsidies towards salaries and social security contributions of companies that use short-time work or voluntarily reduce working time or when the employees were continuously in employment, as provided for in Art. 15g, 15ga, 15gga, 15gg, 15zzb, 15zze and 15zze 2 of the “Act of 2 March 2020 on specific solutions related to the prevention, counteraction and eradication of COVID-19, other infectious diseases and crisis situations caused by them”;
(d)
subsidies to self-employed persons without employees as provided for in Art. 15zzc of the “Act of 2 March 2020 on specific solutions related to the prevention, counteraction and eradication of COVID-19, other infectious diseases and crisis situations caused by them”;
(e)
loans convertible into subsidies granted to self-employed persons, micro-companies and non-government organisations, for the amount actually converted into grants, as provided for in Art. 15zzd and 15zzda of the “Act of 2 March 2020 on specific solutions related to the prevention, counteraction and eradication of COVID-19, other infectious diseases and crisis situations caused by them”;
(f)
financing the performance of PCR diagnostic tests in the laboratories that concluded contracts on performing diagnostic RT-PCR tests for SARS-CoV 2 with the National Health Fund, as provided for in Art. 10a paragraphs 1 and 2, and, after the expiry of Art. 10a, Art. 11h paragraph 2 point 2 and paragraph 4 of the “Act of March 2, 2020 on specific solutions related to the prevention, counteraction and eradication of COVID 19, other infectious diseases and crisis situations caused by them”;
(g)
granting additional monthly cash benefit for medical professionals and one-off additional cash benefit for other healthcare workers, as provided for in Art. 10a paragraph 1 of the “Act of March 2, 2020 on specific solutions related to the prevention, counteraction and eradication of COVID-19, other infectious diseases and crisis situations caused by them” and, after the expiry of Art. 10a, Art. 42 the “Act of August 14, 2020 on amending certain acts in order to ensure the functioning of health protection in connection with the COVID-19 epidemic and after it has ceased”.’.